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Objective. To investigate the incidence of Gestational Diabetes Mellitus at the Mt. Hope Women’s Hospital and to describe its
epidemiological pattern. Design. A retrospective observational study (Jan 2005 to Dec 2007). Setting. A teaching hospital of The
University of the West Indies. Population/Sample. Pregnant women who gave birth. Methods. A sample size of 720. The variables
analyzedwere:age,ethnicity,BMIofmother,familyhistoryofdiabetes;historyofGDM,obstetrichistory,birthweightandAPGAR
score of infant. Main Outcome Measures. (1) Incidence of cases of GDM. (2) Impact of the measured variable. Chi-squares, odds
ratiosandlogisticregressionwereperformed.Results.TheincidenceofGDMwas4.31%(95%C.I.2.31%,6.31%).Theproportion
of GDM patients for the years 2005, 2006, and 2007 were 1.67%, 4.58%, and 6.67%, respectively. Age, Obesity Ethnicity, Family
history of diabetes and a history of GDM were determined risk factors. Associations between GDM and (1) Mode of Delivery
and (2) APGAR score of the baby were found. Discussion & Conclusion. There was an apparent increase in the incidence of GDM.
Additional studies should be conducted to measure the occurrence of GDM in Trinidad and Tobago. Eﬀorts to promote public
awareness and a healthy lifestyle should be made to reverse this trend.
Copyright © 2009 M. Clapperton et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Pregnancy is a diabetogenic state whereby insulin sensitivity
decreases with advancing gestational age [1]. Gestational
diabetes mellitus (GDM) is deﬁned by the World Health
Organization (WHO) as carbohydrate intolerance result-
ing in hyperglycaemia of variable severity with onset or
ﬁrst recognition during pregnancy [2, 3]. This may be
due to previously unrecognized pregestational DM (pre-
GDM) or true GDM, that is, undetected DM type 2
occurring prior to and independent of the pregnancy. The
WHO, further deﬁnes GDM as a fasting plasma glucose
level ≥7.0mmol/L (≥1.26g/L) or a casual plasma glucose
≥11.1mmol/L (≥2.00g/L), conﬁrmed on a subsequent day
[3].
The risks to the foetus include increased birth weight and
risk of perinatal morbidity and mortality [3]. Furthermore,
GDM is associated with increased risk of maternal morbidity
and the development of type 2 diabetes mellitus (T2DM)
[4, 5]. Maternal age, a ﬁrst degree relative with diabetes,
ethnicity, and obesity are primary risk factors for developing
GDM.
In 2001, GDM aﬀected up to 14% of the pregnant
population in the United States [6]. Also, the risk of GDM
recurring has been reported to be 60% to 90% [6]. As much
as 50% of women with GDM will develop overt T2DM after
25 years [7]. In 2000, approximately 19 million people from
Latin America and the Caribbean suﬀered from T2DM [6].
This number is expected to double by the year 2025 [8].
A literature review revealed no published data on the
prevalence of GDM in Trinidad and Tobago. Hence, it is
important to measure the occurrence of GDM in order to
(1) provide evidence on the magnitude of the problem and
its impact on the delivery of care, particularly enhanced
screening and intervention at the primary care level and (2)
guide policy and decision making especially when allocating
precious resources. The purpose of this study is to estimate
theprevalenceofGDMinwomenwhohavegivenbirthatthe
Mt.HopeWomen’sHospitalanddescribeitsepidemiological
pattern.2 Obstetrics and Gynecology International
2.Methodology
This study utilized retrospective clinical data obtained from
patients admitted and followed through to delivery at the
MHWH, a teaching hospital, which services clients mainly
from the Northern half of the island for the period January
2005 to December 2007. Previous studies reporting any
prevalence of GDM in the studied population were not
available. Therefore, in order to validate our ﬁndings, a
census was conducted as a pilot study to determine the
incidence of GDM cases occurring between January and May
2008. The admission registers on the antenatal wards were
used to identify both conﬁrmed and queried diagnoses of
GDM cases. Each ﬁle was reviewed to conﬁrm the presence
of a diagnosis of GDM and followup notes till delivery.
Only individuals with known risk factors were usually
subjected to a 50g oral glucose challenge, if abnormal a
75g oral glucose tolerance test (OGTT) is done to conﬁrm
the diagnosis. All other patients only have a random blood
glucose test done at their ﬁrst visit to the institution. If
random blood glucose tests for nonrisk patients are normal,
another random blood glucose test is conducted at 36 weeks
gestation. Pregnant women who meet WHO criteria for
diabetes mellitus or impaired glucose tolerance (IGT) are
classiﬁed as having GDM. After the pregnancy, the woman
is reclassiﬁed as having either DM, or IGT, or normal glucose
tolerance based on the results of a 75g OGTT six weeks or
more after delivery [2]. The diagnosis of GDM for this study
was based on the diagnosis made and recorded by attending
physicians which were then extracted from the patient’s ﬁle.
The Monthly Report of Inpatient Services was obtained
from the records department to determine the total number
of deliveries for the period which was then used as the
denominator for calculating the rate of occurrence of GDM
for the period January to May 2008. From the 1896 patients
admitted to the hospital during January to May 2008, the
proportion of GDM patients was 2.9% ≈ 3%. This rate was
used as the estimated occurrence of GDM in other years.
The birth registries provided the total number of deliveries
for each year. The total number of deliveries for the 3 years
(January 2005 to December 2007) was 12 655 from which
a minimum sample size of 715 was calculated using the
formula:
n ≥
4Z2
α/2p

1 − p

w2 (1)
(estimated prevalence p = 3%, α = 0.05, and precision w =
2.5%) [9].
Each ﬁle was selected using systematic sampling [9]. In
oursetting, therearenodigitallystoredpatientrecords.Only
hardcopies are ﬁled and stored in the records department.
These ﬁles were not listed in any particular order in the
registry. All deliveries for each year were recorded in a
delivery book in an arbitrary sequence. On average, 20
ﬁles were able to be retrieved per day, thus restricting the
possibility of evaluating the entire population (12655). Since
the total number of deliveries for each year varied by less
than 2%, the subset taken for each year was uniform. The
ﬁrst ﬁle number was randomly selected. Every subsequent
nth ﬁle was selected until 238 ﬁles were selected for each
year. However, 240 ﬁles were selected to increase the sample
size to 720. “n” was calculated by dividing the population
of births for the three years by our sample size estimate
(12655 † 714 ≈ 20), thus every 20th ﬁle was selected. Each
participant selected was reviewed to determine eligibility for
entry into the study.
The exclusion criteria were (1) women who gave birth
at the MHWH before January 2005 and after December
2007, (2) miscarriages before 28 weeks of gestation, and (3)
women with a previous diagnosis of diabetes (Type 1 or Type
2). If a record satisﬁed any of the exclusion criteria, it was
discarded and replaced using the same procedure previously
outlined, by retrieving the subsequent 20th ﬁle, that is, after
the last selected ﬁle for the respective year. Similarly, if a
patient’s record was incomplete such that age, gestational age
at delivery, date and mode of delivery, parity and gravidity
were omitted, it was also replaced. Because the likelihood of
developing GDM in subsequentpregnancies forwomenwith
a history of GDM was also being assessed, each participant
was treated as a new and independent case regardless of a
previous inclusion into the study in a previous year.
To control and validate the data extracted, an initial
trial run was performed by the authors of the study to
determine the feasibility and reliability for abstracting the
data. Following that, abstractors were trained and monitored
to prevent disparities in data collection. Two persons were
assigned to inspect each ﬁle retrieved and recheck data upon
entry. Also, the authors were always present to oversee data
collection. All data was retrieved, stored, and analyzed using
the Statistical Package for Social Sciences (SPSS) Version
15.0.
The variables analyzed were age, ethnicity, gravidity,
parity, BMI of mother at booking or ≥34 weeks gestation,
family history of diabetes; history of gestational diabetes,
gestational age at delivery, mode of delivery (Caesarian
section/Vaginal delivery), complications at delivery, birth
weight of infant, and APGAR score of infant. A binary
logistic regression analysis was performed to determine
the extent of association the investigated risk factors had
with GDM. Potential confounders leading to elevated blood
glucose levels were (1) pathological conditions, for example,
acromegaly, and hyperthyroidism and (2) medical/surgical
treatments, for example, pancreatectomy, glucocorticoid
treatment, and β-adrenergic agonists. The outcome variable
was the proportion of participants who met the WHO
criteria for GDM among mothers who gave birth within
the third trimester. The study was approved by the ethics
committee of the University of the West Indies.
3. Results
Of the 720 women who were eligible for entry into the
study, 31 participants met the criteria for GDM. The overall
proportion of women with GDM was 4.31% (95% CI
2.31%–6.31%) for the period January 2005–December 2007
(see Table 1).The proportion of GDM patients for the years
2005, 2006, and 2007 were 1.67%, 4.58%, and 6.67%,
respectively, indicating an increasing trend. Using this trend,Obstetrics and Gynecology International 3
Table 1: Demographics of study sample.
Number of cases (number with gestational diabetes) Total
Age ranges
≤14 15–19 20–24 25–29 30–34 35–39 40+ Total
No. of patients 1 115 (3) 224 (6) 173 (5) 139 (5) 62 (9) 6 (3) 720 (31)
Gravidity ranges
Primigravida Secundigravida Multigravida Grand multigravida
(0 previous (1 previous (2–4 previous (5 or more previous Total
pregnancies) pregnancy) pregnancies) pregnancies)
No. of patients 210 (11) 186 (5) 209 (10) 115 (5) 720 (31)
Ethnicity
Indo-
trinidadian
Afro-trinidadian Caucasian Chinese Mixed Unknown Total
No. of patients 253 (19) 277 (8) 0 1 138 (2) 51 (2) 720 (31)
Weight of mother at booking
40–50Kg 51–60Kg 61–70Kg 71–80Kg 81–100Kg 101–120Kg >121Kg Unknown Total
No. of patients 17 71 111 (1) 109 (10) 132 (13) 35 (3) 9 236 (4) 720 (31)
Body mass index of mother at booking
<18.5 18.5–24.9 25–29.9 >30 Unknown Total
No. of patients 9 72 (1) 72 (10) 107 (12) 460 (8) 720 (31)
Mode of delivery
Spontaneous Caesarian Total
vaginal section
No. of patients 595 (18) 125 (13) 720 (31)
Weight of baby at delivery
<2.5 2.5 – 4.0 >4.0 Total
No. of patients 98 (7) 595 (21) 27 (3) 720 (31)
a predicted value of 9.31% was calculated for 2008. However,
the actual value is expected to lie between 6.67% and 9.31%.
The mean age of mothers in the sample was 30.4
years (95% C.I. 27.7, 33.1). The age range 35–39 had the
highest proportion of GDM (Pearson Chi-Square P = .001).
Additionally, it was 4 times more likely for GDM (OR 4.07
95% C.I. 1.96, 8.45) to occur in women aged 30–34 than
women <30. However, women ≥35 were 8 times more likely
to acquire GDM (OR 8.00 95% C.I. 2.17–29.5).
The sample population consisted of South East Asians
(35.1%), Africans (38.5%), Mixed (19.2%), and other eth-
nicities (7.2%). South East Asians (P = .016) were 2.7 times
morelikelytodevelopGDMthanAfricans(OR2.7395%C.I.
1.17, 6.35). Also, South East Asians (P = .011) were 5.5 times
more likely to develop GDM than Mixed (OR 5.521 95% C.I.
1.27, 24.07).
AmeanBodyMassIndex(BMI)of28.69(95%C.I.27.90,
29.48) was calculated for the 260 women who had consis-
tently recorded measurements. Sixty-eight percent of these
women were either overweight or obese. The association
(P = .013) between women with healthy BMI’s (18.4–24.9)
and obese women (BMI > 30) revealed that obese women
were 9 times more likely to acquire GDM (OR 8.97 95%
C.I. 1.14, 70.58). Due to the large conﬁdence interval, it is
recommended that a larger study be done to strengthen this
association. However, previous studies have also reported on
this association. It was also observed that the proportion of
GDM cases increased with increasing BMI (see Table 2).
Ofthe720women,17.4%deliveredviaCaesarianSection
(CS). Among the 31 diagnosed cases of GDM, 41.9%
delivered via CS. It was 3.7 times more likely for those with
GDM (P = .000) to have a CS (OR 3.72 95% C.I. 1.77, 7.81).
The mean 5 minute APGAR score for the entire sample was
8.87 (95% C.I. 8.81, 8.92). Even though many studies have
stated a normal APGAR score to be ranged 7 to 10 , no
association was found between the presence of GDM and a
scorebelow7;duetotheinsuﬃcientdataobtainedtoanalyze
APGAR scores less than 7, a 5 minute APGAR less than 8
was subsequently utilized. Women with GDM (P = .023)
were 4 times more likely to deliver a child with a 5 minute
APGAR score of <8 (OR 3.98 95% C.I.1.77, 7.81) than
women without GDM. The mean weight of the neonates at
delivery was 3.05kg (95% C.I. 3.01, 3.10). The mean weight
of the neonates within those diagnosed with GDM was 3.12
(95% C.I. 2.84, 3.40). No signiﬁcant association could be
found.
Approximately 19.4% of women with GDM in their
current pregnancy had a history of GDM. An association
(P = .000) between history of gestational diabetes and
currently developing GDM revealed that a woman with4 Obstetrics and Gynecology International
Table 2: Odds-ratios and Pearson chi-square tests.
95% Conﬁdence interval 95% Conﬁdence interval
Pearson Odds Lower Upper Pearson Odds
Lower Upper
chi-square ratio chi-square ratio
Age Caesarian section
30–34/<30 0.0001 4.07 1.96 8.45 GDM/No GDM 0.0001 3.72 1.77 7.81
>35/<30 0.0001 8 2.17 29.5 APGAR
Ethnicity < 7/ (7–10) —— ——
South-East Asian/Africans 0.016 2.73 1.17 6.35 < 8/ (8–10) 0.023 3.98 1.77 7.81
South-East Asian/Mixed 0.011 5.52 1.27 24.07 Hx of GDM 0.000 41.1 10.91 154.87
BMI Family Hx of GDM 0.001 3.24 1.55 6.8
Obese/Healthy 0.013 8.97 1.14 70.58 Birth weight — — ——
Table 3: Binary logistic regression.
B S.E. Wald df Sig. Exp(B) 95.0% C.I. for EXP(B)
Lower Upper
Step1(a) Ages (15–30) & (>30) −1.289 .446 8.358 1 .004 .276 .115 .660
Healthy (18.4–24.9) &Obese (>30) BMI .212 .069 9.385 1 .002 1.236 1.079 1.415
Africans, South East Asians & Mixed .683 .353 3.750 1 .043 1.981 1.092 3.956
History of GDM 3.181 .809 15.473 1 .000 24.075 4.934 117.478
Family history of GDM .860 .451 3.627 1 .037 2.362 1.975 5.722
Gestational age at delivery .117 .102 1.301 1 .254 1.124 .920 1.373
APGAR (<7) & (7–10) 1.298 1.722 .568 1 .451 3.662 .125 107.074
APGAR (<8) & (8–10) .883 1.288 .471 1 .493 2.419 .194 30.184
Infant underweight, normal, overweight −1.279 .596 4.608 1 .032 .278 .087 .895
Constant −5.500 3.474 2.506 1 .113 .004
avariable(s)enteredonstep1:age range4,obesity severity2,Ethnicity2,hist gest diab,fam hist diab,ges age deliv,apgar score3,apgar range2,weight baby
ranges.
a history of GDM was 41 times more likely to develop GDM
in her subsequent pregnancy (OR 41.10 95% C.I. 10.91,
154.87). Approximately, 34% of the entire sample had a
family history of diabetes. This proportion increased when
observing those with GDM (61.3%). A strong association
between family history of diabetes and GDM (P = .001)
showed that patients with a family history were 3 times
more likely to develop GDM (OR 3.24 95% C.I. 1.55, 6.8).
The results of binary logistic regression analysis showed
associations between GDM and age, BMI, ethnicity, family
history of GDM and history of GDM, and birth weight of
infant (see Table 3).
4. Discussion
The proportion of women with GDM who gave birth at the
MHWH during the period January 2005 to December 2007
was 4.3% (95% CI 2.31%, 6.31%). Regionally, Barcel´ oa n d
Rajpathakin2001reportedaprevalence4%amongpregnant
women in the Americas [10]. The prevalence of GDM may
rangefrom1%to14%,dependingonthepopulationstudied
and the diagnostic tests employed [10]. The proportion of
birth mothers with GDM at the MHWH increased from
1.67% in 2005 to 6.67% in 2007 and is projected to reach
9.31% in 2008, that is, a 5.6-fold increase from 2005. Several
factors may have contributed to this ﬁnding particularly (1)
an increase in the awareness and diagnosis by physicians, (2)
the establishment of a diabetic clinic in 2005, and (3) an
actual increase in the incidence of GDM in the population.
Since there was no information to suggest an increase in
surveillance and any formal government interventions (e.g.,
with respect to screening) introduced to contribute toward
a measured increase, such trend may will be due to a
true increase in the incidence of GDM in the population.
However, larger studies must be conducted to actually
determine the reason for the trend observed.
Obesity in the Caribbean has doubled in ten years
and is now common. The epidemic has been aided and
abetted by the fast food industry, with a proliferation of fast
food restaurants throughout the Caribbean. The transition
of agriculturally based societies to service-based ones has
taken its toll. With development, there has come increasing
mechanization,adeclineinmanuallabor,andimprovements
in transportation. Thirty-four percent of adults in Trinidad
and Tobago are sedentary. Leisure-time physical activity
in the region is the lowest in Trinidad and Tobago [11].
In keeping with this trend, it was observed that a large
proportion of the study population had unhealthy BMIs,Obstetrics and Gynecology International 5
that is,68%wereoverweight(BMI>25)and41%wereobese
(BMI > 30).
Both obesity and a family history of T2DM represent
important risk factors for the development of GDM [12]. It
wasfoundthatobesewomeninthisstudywereatthegreatest
risk of developing GDM (OR 8.97, P ≤ .05) compared to
nonobese participants. Additionally, a 2006 study conducted
in the United Kingdom demonstrated that insulin resistance
was the most signiﬁcant change which predisposed obese
pregnant women to GDM [13]. Thus, we recommend that
allpatientswhohavetheirBMImeasuredtoestablishobesity
and following delivery should be monitored and managed to
achieve a target BMI of 18.5–24.9kgm−2.W e i g h tl o s sd u r i n g
pregnancy is not advisable as there are no evidence-based
guidelines to support this practice.
South East Asians (OR 2.73, P ≤ .05) were found to have
a higher risk of GDM than Africans. Also, women with a
family history of GDM (OR 3.0, P ≤ .05) or a past medical
history of GDM (OR 41, P ≤ .05) were more likely to
develop GDM than those without. It may be inferred that
this was probably due to dietary diﬀerences and/or a genetic
predisposition (familial T2DM).
In accordance with past studies, women with GDM were
more likely (OR 3.72, P ≤ .05) to have a caesarian delivery
as opposed to a vaginal delivery. Other than macrosomia,
the increased risk of caesarean delivery for women with
GDM may also be due to clinical practices at the health
institution and the rate of physician referrals to high-risk
care [14]. When compared to babies born to non-GDM
mothers, those born to mothers with GDM were at higher
risk (OR 3.98 P ≤ .05) of having a lower ﬁve-minute
APGAR score (<8). A low APGAR score usually implies
infant mortality, neonatal neurologic morbidity, and poor
long-term outcome. A 2001 study conducted in Sweden
by Thorngren and Herbst reported that infants with a 5-
minute APGAR score <7w e r em o r el i k e l yt oh a v es e i z u r e s ,
intracranial haemorrhages [15].
Women30–34werefoundtobeatagreaterrisk(OR4.07
P ≤ .05) than those 15–29, and this doubled for women over
35 (OR 8 P ≤ .05). While older women appear more likely
to develop GDM, this could be explained by multigravidity
in older women as well as weight retention from previous
pregnancies contributing to subsequent obesity.
In conclusion, 4.3% of the women who gave birth at the
MHWH during January 2005–December 2007 had GDM.
Since the prevalence of GDM seems to be increasing at
an alarming rate (1.6% in 2005 to 6.7% in 2007), it is
crucial to heighten postpartum vigilance for T2DM via the
commencement of early and long-term screening. Since
other factors may have contributed toward this increase, it
is thus recommended that larger studies are conducted in
order to assess the magnitude of the problem and determine
whether or not the trend observed is in fact due to an
actual increase in the true occurrence of GDM. It is also
proposed that the following WHO and American Diabetes
Association recommendation be implemented: initiation of
screening for T2DM at 6–12 weeks postpartum by either
the measurement of fasting plasma glucose levels or the 75g
oral glucose tolerance test (OGTT) [16, 17]. If results are
normal, then the patient should be reevaluated every 3 years;
if impaired glucose tolerance is detected, annual screening
is then recommended. GDM identiﬁes a population of
women at high risk for developing subsequent T2DM; it
represents an early stage in the natural history of the disease
and therefore provides an opportunity for early interven-
tion and reduction of the national prevalence of T2DM
[18, 19].
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